发明名称 FUSED AZOLE DERIVATIVE
摘要 <p>The present invention provides agents for treating or preventing diseases such as mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disease, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injury, inflammation, immune-related disease, alopecia. Specifically, the invention provides fused azole derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof that have an antagonistic action against the arginine-vasopressin 1b receptor:</p>
申请公布号 EP2832722(A1) 申请公布日期 2015.02.04
申请号 EP20130767453 申请日期 2013.03.29
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 YOSHINAGA, MITSUKANE;ISHIZAKA, TOMOKO;WAKASUGI, DAISUKE;SHIROKAWA, SHIN-ICHI;HATTORI, NOBUTAKA;KASHIWA, SHUHEI;KUWADA, TAKESHI;SHIMAZAKI, YOUICHI
分类号 C07D209/10;A61K31/405;A61K31/4184;A61K31/438;A61K31/454;A61K31/4545;A61K31/5377;A61K31/5386;A61K31/55;A61P1/14;A61P7/10;A61P9/10;A61P9/12;A61P17/14;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/28 主分类号 C07D209/10
代理机构 代理人
主权项
地址